Lilly weight-loss pill works as well as Ozempic, shares surge

By Deena Beasley and Manas Mishra (Reuters) -Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of diabetes patients, and the company said it expects to seek regulatory approvals by the end of the year. Shares jumped 13.3% as the results of the long-awaited trial, the first of several underway on the pill, orforglipron, raised